Tadalafil Tablet
Product Images NDC 70518-3864

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Tadalafil (NDC 70518-3864). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

FDA Label Image

F35596a7-figure-01 (F35596a7 Figure 01)

FDA Label Image

F35596a7-figure-02 (F35596a7 Figure 02)

FDA Label Image

F35596a7-figure-03 (F35596a7 Figure 03)

FDA Label Image

F35596a7-figure-04 (F35596a7 Figure 04)

FDA Label Image

F35596a7-figure-05 (F35596a7 Figure 05)

FDA Label Image

F35596a7-figure-06 (F35596a7 Figure 06)

FDA Label Image

F35596a7-figure-07 (F35596a7 Figure 07)

FDA Label Image

F35596a7-figure-08 (F35596a7 Figure 08)

LS Mean Change from Baseline is a measurement used in clinical trials to determine the average difference between treatment groups. In this case, the treatments being compared are TadalafilFinasteride and PlaceboFinasteride. The text also mentions "Least Squares Treatment Difference," which likely refers to a statistical method used to analyze the data and determine the significance of the treatment effects.*

FDA Label Image

F35596a7-figure-09 (F35596a7 Figure 09)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.